Tag: nuclear imaging for neuroendocrine tumors
![Lale Kostakoglu Shields MD MPH April 15 2021](https://www.carcinoid.org/wp-content/uploads/2021/04/Lale-Kostakoglu-Shields-MD-MPH-April-15-2021-300x300.jpg)
Dr. Lale Kostakoglu-Shields to Be Featured Guest for Luncheon with the Experts
Lale Kostakoglu-Shields, MD, MPH, a nuclear medicine expert, will be the featured guest for CCF’s Luncheon with the Experts on Thursday, April 15, 2021 from 12 noon to 1 pm, Eastern Time. Dr. Kostakoglu-Shields is a professor of radiology and medical…
READ MORE![CCF FB LIVE Ebhrahim S. Delpassand MD April8](https://www.carcinoid.org/wp-content/uploads/2021/03/CCF-FB-LIVE-Ebhrahim-S.-Delpassand-MD-April8-300x300.jpg)
Dr. Ebrahim Delpassand to be Featured Guest for CCF’s Luncheon with the Experts
Ebrahim S. Delpassand, MD, FACNM, Chairman and Medical Director at Excel Diagnostics & Nuclear Oncology Center in Houston, Texas and founder, Chairman of the Board, and CEO of Radiomedix in Houston, will be the featured guest for Luncheon with the…
READ MORE![gallium 68 scan at mt sinai 2015 2](https://www.carcinoid.org/wp-content/uploads/2015/02/gallium-68-scan-at-mt-sinai-2015_2.jpg)
First Northeastern Facility Offers Gallium-68 DOTATOC PET/CT Imaging for Carcinoid and Neuroendocrine Cancer Patients
When Brian Hakimian had the 68Gallium DOTATOC PET/CT scan at the Icahn School of Medicine, Mount Sinai in New York City on January 14, 2015, he became the first carcinoid patient to undergo this novel imaging test at a northeastern facility. Now in clinical…
READ MORE![gallium 68 dota tate chemical structure](https://www.carcinoid.org/wp-content/uploads/2014/06/gallium-68-dota-tate-chemical-structure.png)
Carcinoid Cancer Foundation Awards Grant to Stanford University
The Carcinoid Cancer Foundation in White Plains, New York has awarded a grant of more than $65,000.00 to Stanford University in California to expand access to its Gallium-68 (Ga-68) DOTA-TATE PET/CT program for carcinoid and neuroendocrine tumor (NET)…
READ MORE